A new international grant programme is backing early-career researchers developing solutions to improve diagnosis, treatment and support for patients with blood cancers.
Early-career South African physicians and scientists have been invited to apply for an international grant programme offering up to €120 000 (approximately R2.2 million) over two years to support research and healthcare initiatives aimed at improving blood cancer care.
The DKMS Impact Grant, established by international non-profit organisation DKMS, aims to support locally driven research and healthcare projects in Africa, Central and South America, and South and Southeast Asia.
The funding programme focuses on improving the diagnosis, treatment, management of complications, supportive care and health system capacity for patients with blood cancers and other haematological diseases.
Patients with malignant and non-malignant haematological diseases worldwide continue to face barriers to timely diagnosis, treatment and care. These challenges are often greater in regions where research funding and specialist healthcare infrastructure are limited.
